Definitive Contract HHSN268201100013C
Award Date 10/25/10
Potential Completion Date 12/4/13
Potential Value $880K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the National Heart, Lung and Blood Institute (NHLBI) to Vala Sciences Inc., a small business, has a ceiling value of $159,401.00. The contract is for the Small Business Innovation Research (SBIR) Program Phase I, a research and development effort focused on biomedical (applied/exploratory) work. Vala Sciences Inc. has previously received prime federal contracts and grants from the National Cancer Institute, National Institute of Neurological Disorders and Stroke,...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $299,923 Small Business Innovation Research (SBIR) Phase I contract to Vala Sciences Inc., a for-profit organization, to develop a microscopic imaging-based assay to identify novel therapeutics for breast cancer. The contract is designated as a total small business set aside. Through past federal grant awards, Vala Sciences has developed screening platforms and assays utilizing human...
- This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Vala Sciences Inc. to conduct Small Business Innovation Research (SBIR) Phase I research and development on the "Development of Novel In-Vitro and In-Vivo Models to Support NeuroHIV Research." The contract was set aside for small businesses and has an ultimate completion date of September 26, 2025. Vala Sciences...
- This is a $223,048 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Vala Sciences Inc., a small business, to develop an in vitro assay to study the initiation of breast cancer metastasis. The contract is a firm fixed-price definitive contract. Vala Sciences has previously received SBIR and project grant awards from the National Institutes of Health (NIH) to develop screening platforms and assays for pharmaceutical testing using...
- This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Wicell Research Institute, Inc., a non-profit organization. The contract, valued at $187,372.95, is for the provision of human pluripotent stem cell lines, testing, and related services to support the NHLBI's biomedical research initiatives. Wicell Research Institute, a subsidiary of the Wisconsin Alumni Research Foundation, is a global...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Stemcell Technologies Inc., a Canadian biotechnology company, to provide specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research initiatives across various government agencies. The contract, valued at...
- This is a federal contract award to Wicell Research Institute, Inc., a non-profit organization, by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services. The contract, valued at $16,137,048.00, is for the provision of human pluripotent stem cell lines, testing, and related services to support biomedical research. Wicell is a global leader in stem cell banking and distribution, and has provided specific cell lines to the National Institutes...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>
- This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Xcell Science Incorporated, a minority-owned, woman-owned small business. The contract has an award value of $1,001,068.00 and a period of performance ending on February 28, 2014. It is a delivery order under the larger "Gene Insertion - Pluripotent Stem Cells 2012-2017" indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract is for professional support...